摘要
文章介绍了美国食品药品监督管理局(The Food and Drug Administration,FDA)法对药品审查流程与标准的相关规定及其发展历程。然后研究分析了美国专利法与FDA法各自法规及其相互作用如何促进美国生物医药创新,并在此基础上,提出了促进中国生物医药创新的建议。
This article introduces the laws of the U.S.Food and Drug Administration(FDA)on the process and standard of drug approval and their evolutions.The interactions of the U.S.Patent Law and the FDA laws in promoting the biomedical innovation in the United States are also analyzed.Based on these analyses,suggestions are proposed to promote biomedical innovation in China.
作者
王润华
Wang Runhua(College of Law,University of Illinois at Urbana-Champaign,IL 61801,USA)
出处
《中国医疗管理科学》
2019年第1期50-55,共6页
Chinese Journal Of Medical Management Sciences
关键词
FDA法
专利法
生物医药
科技创新
美国
FDA laws
Patent law
Biomedicine
Sci-Tech Innovation
United States